General Information of the Molecule (ID: Mol02137)
Name
Miltefosine transporter beta subunit (ROS3) ,Mycobacteroides abscessus
Synonyms
Miltefosine transporter beta subunit; Ros3
    Click to Show/Hide
Molecule Type
Protein
Gene Name
Ros3
Sequence
MAPLPPKPHSKNRIEQQQLPHIYARHSPLSVSVVFFILAVAAIPIGVLVIVSGDLTTRLD
FRYDHINSYKFAMGAAGEFAVNFPFNGTMYSSGVKTRLMFSLHQSLTAPVYMQYRLSPFF
QNYRYFTASVDYSQLSGRASAISKLCAPFRFPGEATGDSVSGYYNPCGAYPWAMFNDSIS
LYRTDGTLICDGSAFTANGTSLAANNKCVKSGIARPSDVKERYNPPREIPGNGPMWSAGG
NKSATDPYLREGYYYKEPGHKIPLSIDEDLIVWLDPAFTSDVTKNYRILNVDLPAGDYYF
EITEQYPTAPYASHKFVQLATRSWIGGRSHVLGSLLIIMGGTAFIMAVTLLSVKYLIMPV
YTEDI
    Click to Show/Hide
Uniprot ID
Q0P0L8_LEIDO
        Click to Show/Hide the Complete Species Lineage
Kingdom: N.A.
Phylum: Actinobacteria
Class: Actinomycetia
Order: Corynebacteriales
Family: Mycobacteriaceae
Genus: Mycobacteroides
Species: Mycobacteroides abscessus
Type(s) of Resistant Mechanism of This Molecule
  IDUE: Irregularity in Drug Uptake and Drug Efflux
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Click to Show/Hide the Full List of Drugs
Miltefosine
Click to Show/Hide
Drug Resistance Data Categorized by Their Corresponding Mechanisms
       Irregularity in Drug Uptake and Drug Efflux (IDUE) Click to Show/Hide
Disease Class: Leishmaniasis [1]
Resistant Disease Leishmaniasis [ICD-11: 1F54.1]
Resistant Drug Miltefosine
Molecule Alteration Expression
Down-regulation
Experimental Note Discovered Using In-vivo Testing Model
Mechanism Description The uptake of MIL and other alkyl-glycerophospholipids in Leishmania requires a translocation machinery that includes a P-type ATPase named the Leishmania miltefosine transporter (LMT), which is responsible for the translocation of phospholipids from the exoplasmic to the cytoplasmic leaflet of the plasma membrane of Leishmania. The function of LMT depends on its binding to a specific B subunit of LMT called LRos3, which belongs to the CDC50/LEM3 protein family. Both proteins are mutually dependent for their function and their localization at the plasma membrane of Leishmania, being required for MIL uptake and susceptibility.
References
Ref 1 Drug resistance and treatment failure in leishmaniasis: A 21st century challenge .PLoS Negl Trop Dis. 2017 Dec 14;11(12):e0006052. doi: 10.1371/journal.pntd.0006052. eCollection 2017 Dec. 10.1371/journal.pntd.0006052

If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.